CACLP 2025 Unites Global Innovators in IVD Industry
|
By LabMedica International staff writers Posted on 11 Mar 2025 |
|
CACLP (Shanghai, China) will be holding the 22nd China International In Vitro Diagnostic Expo, the largest and most influential gathering of the IVD industry in China, 22-24 March 2025 at the Hangzhou Grand Convention & Exhibition Center. CACLP 2025 promises to be a world-class showcase of the latest innovations, professional networking and business opportunities.
Over 1,300 exhibitors will present their cutting-edge technologies across seven major categories spanning Halls 2 to 8, with more than 60 companies launching their new products onsite. CACLP 2025 will also feature dedicated Canada and Germany Pavilions, highlighting the leading diagnostic companies and innovations from North America and Europe. Government entities, medical associations, and industry organizations from countries including Canada, Germany, India, South Korea, Switzerland, the U.K., the U.S., Vietnam and beyond will actively participate, contributing to onsite discussions, especially dozens of regulatory and product innovations roadshows in the Presentation Area of Halls 5 and 7. With professional visitors and international buyers recruited from key markets worldwide, CACLP 2025 will serve as a premier platform for global networking and cross-border collaboration.
As a hub for AI and technology advancements, Hangzhou provides the perfect backdrop for CACLP 2025, which will introduce the 1st AI and Digital Twin Technology Academic Salon, exploring the transformative role of AI in diagnostics. Additionally, onsite activities will spotlight many key industry trends, including veterinary diagnostics, global investment, and primary healthcare. The event will debut three groundbreaking forums addressing critical industry shifts. The 1st Human-to-Animal Medical Device Transition Forum, co-hosted with the East and West Small Animal Veterinary Conference, will examine how human diagnostic innovations are shaping the veterinary healthcare market, with a focus on standardization, regulations, and commercialization. The 1st National Primary Healthcare Laboratory Forum addresses quality control, test result standardization, and access to advanced diagnostics, supporting the growth of grassroots laboratory services. The 1st China IVD Companies Globalization Forum will feature insights from government officials, regulatory experts, and industry leaders, providing strategic guidance on global market trends, regulatory pathways, and international expansion.
In addition to the exhibition and newly launched activities, CACLP remains a hub for academic and industry dialogues. Further high-level conferences and forums will be primarily held in Hall 1 – the Convention Center. The 10th China Experimental Medicine Conference (CEMC), themed "A Decade Together for a Shared Future", will bring together leading academicians, hospital presidents, and experts in experimental medicine and biomedical engineering. Discussions will cover early disease screening, personalized treatment, AI integration, and other cutting-edge advancements. The conference will also feature sessions dedicated to pathology, molecular diagnostics, coagulation, mass spectrometry, and more specific topics. The 12th China IVD Industry Development Conference (CIIDC), under the theme "Empowering the Future with New Intelligence", will explore the future of the IVD industry through discussions on sustainability, international expansion, healthcare reforms, technological advancements, investment strategies, and industry development.
A key highlight will be the official release of the Annual Report of China IVD Industry 2024, providing essential insights into market performance and trends. Additional forums including Enlightening Lab Med – The 8th IVD Youth Entrepreneur Forum (ELMY), the 7th China IVD Distribution Enterprise Forum (CIDEF), and the 5th China Key Raw Material & Parts Forum (CKRMPF), will offer targeted discussions for different segments of the IVD industry. With two main tradeshows and over 100 concurrent activities, and unmatched networking opportunities, CACLP 2025 is the go-to event for professionals in diagnostics, laboratory medicine, and healthcare.
Related Links:
CACLP
Latest Industry News
- Bio-Rad to Acquire Digital PCR Developer Stilla Technologies
- ABL Signs Know-How License and Transfer Agreement for Siemens’ Fast Track Diagnostics PCR Portfolio
- Becton Dickinson to Spin Out Biosciences and Diagnostic Solutions Business
- New Partnership Revolutionizes Analyses of Biological Samples
- Medlab Middle East Looks to The Future of Laboratories
- Medix Biochemica Acquires German Immunoassay Solutions Developer Candor Bioscience
- bioMérieux Acquires Norwegian Immunoassay Start-Up SpinChip Diagnostics
- Danaher Partners with Healthcare AI Company Innovaccer on Novel Digital and Diagnostic Solutions
- OraSure Technologies Acquires Sherlock Biosciences
- Worldwide Initiative Aims to Develop Globally Generalizable Blood-Based Tests for Alzheimer’s Disease
- Hologic Enters into Agreement with CDC for H5N1 Bird Flu Test Development
- Quanterix Acquires Magnetic Bead Tech Firm Emission
- LGC Acquires German Quality Controls Maker DiaMex
- Bio-Techne and ALZpath Partner to Advance Neurodegenerative Disease Research and Treatment
- Microbiologics Acquires Diagnostic Quality Controls Manufacturer SensID
- Beckman Coulter Partners with BioPorto for Global Distribution of Acute Kidney Injury NGAL Tests
Channels
Clinical Chemistry
view channel
Paper-Based Device Boosts HIV Test Accuracy from Dried Blood Samples
In regions where access to clinics for routine blood tests presents financial and logistical obstacles, HIV patients are increasingly able to collect and send a drop of blood using paper-based devices... Read more
AI-Powered Raman Spectroscopy Method Enables Rapid Drug Detection in Blood
Accurately monitoring drug levels in the blood is essential for effective treatment, particularly in the management of cardiovascular diseases. Traditional techniques for monitoring blood drug levels often... Read more
Novel LC-MS/MS Assay Detects Low Creatinine in Sweat and Saliva
Timely and accurate monitoring of renal function is essential for managing patients at risk of acute kidney injury (AKI), which affects about 12% of hospitalized patients and up to 57% of ICU patients.... Read more
Biosensing Technology Breakthrough Paves Way for New Methods of Early Disease Detection
Nanopores are tiny openings that can detect individual molecules as they pass through, making them ideal for analyzing biomolecules like DNA and proteins. However, detecting proteins at extremely low ... Read moreMolecular Diagnostics
view channel
Blood Test Could Help More Women Survive Aggressive Triple Negative Breast Cancer
Cancer research shows that over 90% of women diagnosed with breast cancer at its earliest stage survive for five years or more. However, this survival rate dramatically decreases to just 30% when the cancer... Read more
CSF Test Distinguishes Prion Disease from Other Causes of Rapidly Progressive Dementia
Rapidly progressive dementias are a category of dementia where patients experience a swift decline from the onset of symptoms to losing functional independence, typically within two years.... Read more
Newly Identified Stroke Biomarkers Pave Way for Blood Tests to Quickly Diagnose Brain Injuries
Each year, nearly 800,000 individuals in the U.S. experience a stroke, which occurs when blood flow to specific areas of the brain is insufficient, causing brain cells to die due to a lack of oxygen.... Read more
CRISPR-Based Test Diagnoses Life-Threatening Fungal Infection More Quickly
Pneumocystis jirovecii pneumonia (PJP) is a serious fungal infection that mainly affects children and those with weakened immune systems. Diagnosing PJP typically requires invasive procedures like bronchoalveolar... Read moreHematology
view channel
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read more
WBC Count Could Predict Severity of COVID-19 Symptoms
The global health crisis caused by the SARS-CoV-2 virus continues to impact millions of people worldwide, with many experiencing persistent symptoms months after the initial diagnosis. Cognitive impairment... Read more
New Platelet Counting Technology to Help Labs Prevent Diagnosis Errors
Accurate platelet count testing is a significant challenge for laboratories. Inaccurate results can lead to misdiagnosis, missed diagnoses, and delayed treatment for a variety of potentially fatal conditions,... Read more
Streamlined Approach to Testing for Heparin-Induced Thrombocytopenia Improves Diagnostic Accuracy
Heparin-induced thrombocytopenia (HIT), a serious side effect of the blood thinner heparin, is difficult to diagnose because thrombocytopenia, or low platelet count, can be caused by a variety of factors... Read moreImmunology
view channel
Cerebrospinal Fluid Test Predicts Dangerous Side Effect of Cancer Treatment
In recent years, cancer immunotherapy has emerged as a promising approach where the patient's immune system is harnessed to fight cancer. One form of immunotherapy, called CAR-T-cell therapy, involves... Read more
New Test Measures Preterm Infant Immunity Using Only Two Drops of Blood
Preterm infants are particularly vulnerable due to their organs still undergoing development, which can lead to difficulties in breathing, eating, and regulating body temperature. This is especially true... Read more
Simple Blood Test Could Help Choose Better Treatments for Patients with Recurrent Endometrial Cancer
Endometrial cancer, which develops in the lining of the uterus, is the most prevalent gynecologic cancer in the United States, affecting over 66,000 women annually. Projections indicate that in 2025, around... Read more
Microbiology
view channel
Gastrointestinal Panel Delivers Rapid Detection of Five Common Bacterial Pathogens for Outpatient Use
Acute infectious gastroenteritis results in approximately 179 million cases each year in the United States, leading to a significant number of outpatient visits and hospitalizations. To address this, a... Read more
Rapid PCR Testing in ICU Improves Antibiotic Stewardship
A collaborative study led by the University of Plymouth (Devon, UK) has shown that rapid polymerase chain reaction (PCR) testing in the intensive care unit (ICU) improved antibiotic stewardship compared... Read more
Pathology
view channel
Informatics Solution Elevates Laboratory Efficiency and Patient Care
QuidelOrtho Corporation (San Diego, CA, USA) has introduced the QuidelOrtho Results Manager System, a cutting-edge informatics solution designed to meet the increasing demands of modern laboratories.... Read more
Microfluidic Device Assesses Stickiness of Tumor Cells to Predict Cancer Spread
Ductal carcinoma in situ (DCIS), a type of early-stage breast cancer, is often referred to as stage zero breast cancer. In many cases, it remains harmless and does not spread beyond the milk ducts where... Read more
New AI Tool Outperforms Previous Methods for Identifying Colorectal Cancer from Tissue Sample Analysis
Tissue analysis typically involves a pathologist reviewing scanned digital slides from a patient’s intestinal sample and marking specific areas, such as those where cancerous and related tissues are present.... Read more
Technology
view channel
POC Paper-Based Sensor Platform to Transform Cardiac Diagnostics
Cardiovascular diseases continue to be the leading cause of death worldwide, accounting for over 19 million fatalities annually. Early detection of myocardial infarction (MI), commonly known as a heart... Read more
Study Explores Impact of POC Testing on Future of Diagnostics
In today’s rapidly changing world, having quick and accurate access to medical information is more crucial than ever. Point-of-Care Diagnostics (PoC-D) and Point-of-Care Testing (PoC-T) are making this... Read more
